1Wong E, DeLuca C, Boily C, et al. Characterization of autocrine inducible prostaglandin H synthaseo2 ( PGHS-2 ) in human osteosarcoma cells[J]. Inflamm Res, 1997, 46(2) : 51 -59.
2Zhang X, Schwarz E M, Young D A, et al. Cyelooxygenase-2 regulates mesenehymal cell differentiation into the osteoblast lineage and is critically involved in bone repair[J]. J Clin Invest, 2002,109( 11 ) :1405 - 1415.
3Ono K, Akatsu T, MuraKami T, et al. Involvement of cyclooxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines [ J ]. J Bone Miner Rcs,2002, 17(5) : 774 -781.
4Ohshiba T, Miyaura C, Ito A, et al. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis[ J]. Biochem Biophys Res Commun, 2003, 24, 300(4): 957 -964.
5Medhurst S J, Walker K, Bowes M, et al. A rat model of bone cancer pain[J]. Pain, 2002, 96(1-2) : 129 -140.
6Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis[ J]. Clin Cancer Res, 2000, 6(2) : 572 - 577.
9Tamura M, Sebastian S, Gurates B, et al. Vascular endothelial growth factor up-regulates cycloexygenase-2 expression in human endothelial cells[J]. J Clin Endocrinol Metab, 2002, 87 (7) :3504 - 3507.
10Bamba H, Ota S, Kato A, et al. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells[J]. Biochem Biophys Res Commun,2000,273(2) :485 -491.
3Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer[J]. J Cell Physiol,2002,190(3) :279 - 286.
4Chow NH, Hsu Pl, Lin XZ, et al. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma:an immunohistochemical study [J]. Hum Pathol. , 1997,28 (6) :698 - 703.
5Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogentic and antitumor of cyclooxygenase-2 inhibitors [J]. Cancer Res, 2000,60 (5):1306 - 1311.
6Sano H,Kawahito Y, Wilder RL,et al. Expression of cyclooxygenase-I and -2 in human colorectal cancer [J]. Cancer Res, 1995,55 (17):3785 - 3789.
7Hida T,Yatabe Y,Achiwa H,et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas [J]. Cancer Res, 1998,58 (17) :3761 - 3764.
8Cheng SY, Huang HJ, N agane M, et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor[J]. Proc Natl Acad Sci U S A, 1996,93 (16): 8502 ～ 8507.
9Cianchi F,Cortesini C,Bechi P,et al. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer [J]. Gastroenterology, 2001,121 (6): 1339 - 1347.
10Masferrer JL,Leahy KM,Koki AT,et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors [J]. Cancer Res, 2000,60(5) :1306 - 1311.
2Castro M G, Cowen R, Williamson I K, et al. Current and future strategies for the treatment of malignant brain tumors[ J ]. Pharmacol Ther,2003,98(1 ) :71 - 108.
3Giardiello F M, Hamilton S R, Krush A J,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis[J]. N Engl J Med,1993,328(18) :1313 - 1316.
4Perdiki M, Korkolopoulou P,Thymara I,et al. Cyclooxygenase-2 expression in astroeytomas. Relationship with microvascular parameters, aogiogenic factors expression and survival [ J ]. Mol Cell Biothem, 2007,295 ( 1-2 ) : 75 - 83.
5Taketo M M. Cyclooxygenase-2 inhibitors in tumorigenesis (part Ⅰ) [ J ]. J Natl Cancer Inst, 1998,90 (20) : 1529 - 1536.
6Castelli M G, Chiabrando C, Fanelli R, et al. Prostaglandin and thromboxane synthesis by human intracranial tumors [ J ]. Cancer Res,1989,49(6) :1505 - 1508.
7Petersen C, Petersen S, Milas L, et al. Enhancement of intrinsic tumor cell radiosensltivity induced by a selective cyclooxygenase-2 inhibitor[ J]. Clin Cancer Res,2000,6(6) :2513 -2520.
8Fujimoto J, Toyoki H, Sakaguchi H, et al. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer[ J]. Oncol Rep,2006,15 ( 1 ) :21 - 25.
9Masunaga R, Kohno H, Dhar D K,et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients [ J ]. Clin Cancer Res, 2000,6 (10) :4064 -4068.
10Korkolopoulou P, Patsouris E, Konstantinidou A E,et al. Hypoxiainducible factor Ⅰ alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry,proliferation and prognosis[ J ]. Neuropathol Appl Neurobiol, 200d, 30( 3 ) : 267 - 278.
